Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses

Overview of attention for article published in Therapeutics and Clinical Risk Management, March 2009

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

patent: 2 patents

Readers on

mendeley: 43 Mendeley

Summary X Patents

So far, Altmetric has seen 2 patents that reference this research output.

Influenza vaccines

Grant US-10251947-B2

United States of America

dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants

Grant US-7943147-B2

United States of America